ARNA : Analysis & Opinions

  1. Arena Pharmaceuticals Dumps Belviq Weight Loss Drug

    January 6, 2017
    Arena transferred the rights to its weight loss drug Belviq to its Japanese partner Eisai.
  2. New Tablet Supports Weight Loss Management (ARNA)

    October 4, 2016
    Arena Pharmaceuticals and Eisai announced the launch of tablets for weight loss management in the United States, a key market.
  3. Arena Launches Drug Discovery Incubator (ARNA)

    September 19, 2016
    Arena Pharmaceuticals has launched an independent drug discovery incubator firm to focus on collaborative activities.
  4. What to Expect in Arena Pharmaceuticals Earnings?

    August 8, 2016
    Lack of revenue growth has prompted the company to last month announce a 73% reduction in its workforce, aimed at boosting ...
  5. Arena Pharmaceuticals to Slash Workforce By 73% (ARNA)

    July 5, 2016
    Arena said the cuts will be primarily in areas of research, manufacturing and general and administrative staff.
  6. Arena Pharmaceuticals Extends Its Winning Streak (ARNA, CELG)

    March 28, 2016
    While Arena is riding a wave of optimism, the company must still execute on its own to get its shares out of penny stock ...
  7. Why Arena Pharmaceuticals Surged 10% Last Week (ARNA)

    March 21, 2016
    Arena Pharmaceuticals, which operates at a negative cash flow of $98 million, saw its stock rise in sympathy to favorable ...
  8. How Speculation Drives Investment in Arena Pharmaceuticals (ARNA)

    March 14, 2016
    Find out the reasons why biotech firm Arena Pharmaceuticals is a speculative play and how speculators are driving investment ...
  9. Analyzing Arena Pharma's Return on Equity (ARNA, IMGN)

    March 8, 2016
    Explore Arena Pharmaceutical's return on equity (ROE) and find out what is driving its significant negative returns. Find ...
  10. The Future of the Marijuana Industry in America

    November 10, 2015
    Polls show that most Americans favor legalization, and studies on the use of medical marijuana have been promising. Should ...
  11. Marijuana Penny Stocks: Where Risk Meets Sin

    September 7, 2015
    Marijuana producers and users, working in a market that's still illegal in many states, are a risky but promising bet for ...
  12. 5 Key Takeaways Following Arena's Q1 Results (ARNA, ESALY)

    May 13, 2015
    Arena Pharmaceuticals (NASDAQ: ARNA) this week reported first-quarter financial results that have investors wondering whether ...
  13. 3 Things Arena's Management Wants You to Know (ARNA, ESALY)

    May 7, 2015
    The battle for market share in the highly competitive obesity market is heating up, and there's likely to be significant ...
  14. 3 Ways Arena Can Boost Shareholder Value (ARNA, IMGN)

    April 2, 2015
    Following the approval of weight control management drug Belviq by the Food and Drug Administration in 2012, Arena Pharmaceuticals ...
  15. Is Arena Pharmaceuticals In Trouble? (ARNA)

    March 5, 2015
    Arena Pharmaceuticals' approval of its weight-loss drug Belviq in 2012 has brought anticipations so high that its share price ...